Toxoplasma gondii total antibody immune blotting kit and preparation method thereof
A technology for immunoblotting and toxoplasma gondii, applied in the field of kits, can solve problems such as high price and achieve the effects of low cost, high sensitivity and wide application
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0033] The preparation method of described toxoplasma gondii total antibody immunoblotting kit comprises the following steps:
[0034] 1) Preparation of SAG1 (P30), SAG2 (P22), ROP2 and GRA7 Toxoplasma gondii recombinant antigens
[0035]Using gene cloning technology, PCR amplified the DNA encoding the T. gondii antigen, and inserted it into Escherichia coli to express it, and obtained the T. gondii recombinant antigens SAG1 (P30), SAG2 (P22), ROP2, and GRA7.
[0036] 2) Spotting on nitrocellulose membrane
[0037] SAG1 (P30), SAG2 (P22), ROP2 and GRA7 Toxoplasma recombinant antigens were coated on the nitrocellulose membrane total antibody detection line, human Ig antibody was coated on the control line, and dried.
[0038] 3) Preparation of anti-human Ig monoclonal antibody
[0039] Immunize Balb / c mice with human Ig as antigen, and obtain a hybridoma cell line that stably secretes anti-human Ig monoclonal antibody through hybridoma technology;
[0040] 4) Horseradish per...
Embodiment 1
[0065] Paste the nitrocellulose membrane on the surface of the carrier plate, and the total antibody detection line and control line of Toxoplasma gondii are arranged on the nitrocellulose membrane in turn; the recombinant antigens SAG1 (P30) and SAG2 (P22) of Toxoplasma gondii are coated at the total antibody detection line of Toxoplasma gondii ), ROP2 and GRA7, coated with human Ig antibody at the control line, cut into strips with a strip cutter, and assembled with enzyme-labeled anti-human Ig monoclonal antibody and its substrate to form a Toxoplasma gondii total antibody immunoblotting kit .
[0066] 1) The sample was diluted 1:50 with 0.01mol / LPBS buffer.
[0067] 2) Blocking: 5% skimmed milk powder (prepared with 0.01 mol / L PBST buffer) was used as the blocking solution, and incubated at room temperature (18-25° C.) on a rocking table for 30 min.
[0068] 3) Serum incubation: take out the required membrane strips, put them into the incubation tank, and number them. Ad...
Embodiment 2
[0076] Similar to Example 1, the difference is that the nitrocellulose membrane detection line only consists of SAG2 (P22), ROP2 and GRA7 Toxoplasma recombinant antigens, and does not contain SAG1 (P30) Toxoplasma recombinant antigens. Result judgment is identical with embodiment 1.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 